Immunogenicity Of Bivalent, Quadrivalent HPV Vaccines Correlated To Cross-Protective Efficacy, Study Indicates
July 01, 2021
Infectious Disease Advisor (6/30, Aghjayan) reports, “Immunogenicity of bivalent and quadrivalent human papillomavirus (HPV) vaccines are correlated to their cross-protective efficacy, with significant differences in induced antibody concentrations 2 to 1...